Literature DB >> 15659756

Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?

Sabine Santibanez1, Stefan Niewiesk2, Alla Heider1, Jürgen Schneider-Schaulies2, Guy A M Berbers3, Albert Zimmermann1, Anne Halenius1, Anne Wolbert1, Ingrid Deitemeier1, Annedore Tischer1, Hartmut Hengel1.   

Abstract

Measles virus (MV) infection and vaccination induce long-lasting immunity and neutralizing-antibody responses that are directed against the MV haemagglutinin (H) and the fusion (F) protein. A new MV genotype, D7, emerged recently in western Germany and rapidly replaced the long-term endemically circulating genotypes C2 and D6. Analysis of the H gene of C2, D6, D7 and vaccine viruses revealed uniform sequences for each genotype. Interestingly, a consistent exchange of seven distinct amino acids in the D7 H was observed when compared with residues shared between C2, D6 and vaccine viruses, and one exchange (D416-->N) in the D7 H was associated with an additional N-linked glycosylation. In contrast, the F gene is highly conserved between MVs of these genotypes. To test whether the D7 H protein escapes from antibody responses that were raised against earlier circulating or vaccine viruses, the neutralizing capacity of mAbs recognizing seven distinct domains on the H of an Edmonston-related MV was compared. The mAbs revealed a selective and complete loss of two neutralizing epitopes on the D7 H when compared with C2, D6 and vaccine viruses. To assess whether these alterations of the D7 H affect the neutralizing capacity of polyclonal B-cell responses, genotype-specific antisera were produced in cotton rats. However, no significant genotype-dependent difference was found. Likewise, human sera obtained from vaccinees (n=7) and convalescents (n=6) did not distinguish between the MV genotypes. Although the hypothesis of selection of D7 viruses by pre-existing neutralizing antibodies is compatible with the differing pattern of neutralizing epitopes on the H protein, it was not confirmed by the results of MV neutralization with polyclonal sera.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659756     DOI: 10.1099/vir.0.80467-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.

Authors:  Rik L de Swart; Selma Yüksel; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Structure of the measles virus H glycoprotein sheds light on an efficient vaccine.

Authors:  Rob W H Ruigrok; Denis Gerlier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

Review 3.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

4.  Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.

Authors:  Camille Lévy; Fouzia Amirache; Caroline Costa; Cecilia Frecha; Claude P Muller; Hasan Kweder; Robin Buckland; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

5.  Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.

Authors:  Miguel Ángel Muñoz-Alía; Claude P Muller; Stephen J Russell
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Authors:  Melissa D Simek; Wasima Rida; Frances H Priddy; Pham Pung; Emily Carrow; Dagna S Laufer; Jennifer K Lehrman; Mark Boaz; Tony Tarragona-Fiol; George Miiro; Josephine Birungi; Anton Pozniak; Dale A McPhee; Olivier Manigart; Etienne Karita; André Inwoley; Walter Jaoko; Jack Dehovitz; Linda-Gail Bekker; Punnee Pitisuttithum; Robert Paris; Laura M Walker; Pascal Poignard; Terri Wrin; Patricia E Fast; Dennis R Burton; Wayne C Koff
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

7.  Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.

Authors:  Maino Tahara; Yuri Ito; Melinda A Brindley; Xuemin Ma; Jilan He; Songtao Xu; Hideo Fukuhara; Kouji Sakai; Katsuhiro Komase; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

8.  Phylodynamic analysis of the canine distemper virus hemagglutinin gene.

Authors:  Guan-Ming Ke; Chin-Hsiang Ho; Meng-Jung Chiang; Bintou Sanno-Duanda; Cheng-Shu Chung; Maw-Yeong Lin; Yong-Ying Shi; Ming-Hui Yang; Yu-Chang Tyan; Pao-Chi Liao; Pei-Yu Chu
Journal:  BMC Vet Res       Date:  2015-07-25       Impact factor: 2.741

9.  Genetic characterization of the hemagglutinin genes of wild-type measles virus circulating in china, 1993-2009.

Authors:  Songtao Xu; Yan Zhang; Zhen Zhu; Chunyu Liu; Naiying Mao; Yixin Ji; Huiling Wang; Xiaohong Jiang; Chongshan Li; Wei Tang; Daxing Feng; Changyin Wang; Lei Zheng; Yue Lei; Hua Ling; Chunfang Zhao; Yan Ma; Jilan He; Yan Wang; Ping Li; Ronghui Guan; Shujie Zhou; Jianhui Zhou; Shuang Wang; Hong Zhang; Huanying Zheng; Leng Liu; Hemuti Ma; Jing Guan; Peishan Lu; Yan Feng; Yanjun Zhang; Shunde Zhou; Ying Xiong; Zhuoma Ba; Hui Chen; Xiuhui Yang; Fang Bo; Yujie Ma; Yong Liang; Yake Lei; Suyi Gu; Wei Liu; Meng Chen; David Featherstone; Youngmee Jee; William J Bellini; Paul A Rota; Wenbo Xu
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.

Authors:  Patrycja J Lech; Gregory J Tobin; Ruth Bushnell; Emily Gutschenritter; Linh D Pham; Rebecca Nace; Els Verhoeyen; François-Loïc Cosset; Claude P Muller; Stephen J Russell; Peter L Nara
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.